Patients Discontinuing Weight-Loss Medications Put On Pounds Far More Rapidly Compared to Dieters

Fresh analysis reveals that individuals who stop using popular slimming jabs like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who stop traditional diet and exercise regimens.

Published data in a leading medical journal points out that while overweight individuals frequently drop a large proportion of their total mass while on the medication, the weight comes back at an average rate of 0.8 kg per month once they quit.

"Individuals purchasing these drugs need to be aware of the potential of rapid weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.

Such speed of regain means a return to original mass in about 18 months.

Analyzing Therapies

The analysis, which reviewed dozens of studies involving thousands of participants, contrasted the effects of GLP-1 agonists with conventional dieting.

The team note that individuals who shed pounds through lifestyle changes alone generally have a slower weight regain—perhaps 100 grams monthly—after stopping.

Understanding the Rapid Regain

Experts believe the mode of action of the drugs explains the accelerated rebound.

GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.

"Long-term administration of GLP-1 concentrations far above than normal may cause the body to produce less of its endogenous hormone, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition expert.

"Withdrawal of this hormone supplement results in appetite is unsuppressed, making excessive eating a significant risk."

A Chronic Condition?

The NHS advise the injections for people with obesity-related health risks, alongside recommended diet and exercise modifications.

A number of clinicians say that, due to the significant potential of relapse, the treatment is often long-term.

This opinion is echoed by pharmaceutical companies, who state that the findings "highlight the persistent character of excess weight," comparing it to managing conditions like hypertension.

User Accounts

Individuals who have discontinued the jabs report a sudden resurgence of cravings.

"I experienced a trigger activating and you're instantly starving," recalled an individual.

This challenge is worsened if individuals have not developed sustainable lifestyle or habit modifications during treatment.

Significant Adoption

Survey data show that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.

• Use is more common among women compared to males.
• The middle-aged demographic shows the greatest usage rates.
• Many obtain the drugs through private healthcare rather than the NHS.

In conclusion, clinicians emphasize that while GLP-1 drugs are effective tools for shedding pounds, they are not a permanent fix and lasting health benefits likely depends on integrated lifestyle support.